Skip to main content

Table 3 Impacts of the DRG payment on treatment efficiency among DR-TB patients

From: Impact of diagnosis-related group payment on medical expenditure and treatment efficiency on people with drug-resistant tuberculosis: a quasi-experimental study design

 

Inpatient frequency

Inpatient LOS per hospitalization

Treatment duration per patient

DID

-1.32*

(0.75)

-2.63 days**

(1.06)

-25.84 days

(39.82)

Control variables

YES

YES

YES

Observations

279

751

279

  1. Standard errors are shown in parentheses. The significance levels of 5%, and 10% are denoted by **, and *, respectively. All regressions controlled individual fixed effects, year fixed effects, and covariates. Covariates include age, sex, marriage status, living area, occupation, drug resistance type, and CCI
  2. DRG: Diagnosis-related group; DID: difference-in-differences; DR-TB: drug-resistant tuberculosis; LOS: length of stay
Back to article page

International Journal for Equity in Health

ISSN: 1475-9276

Contact us